These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4712072)

  • 1. [Antitubercular activity and concentrations of rifampicin and ethambutol in the organs].
    Drabkina RO; Ginzburg TS
    Vrach Delo; 1973 Apr; 4():51-4. PubMed ID: 4712072
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study of rifampicin and ethambutol].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1971; 49(1):64-8. PubMed ID: 5576515
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].
    Ibarra JP; Costa de Mello B; Mazza de Pratto N
    Hoja Tisiol; 1969; 26(1):113-26. PubMed ID: 5401724
    [No Abstract]   [Full Text] [Related]  

  • 7. An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
    Hokama S
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):57-61. PubMed ID: 5317096
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F; Canetti G; Le Lirzin M
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum rifampicin level in children with tuberculosis and in young mice].
    Zwolska-Kwiek Z; Ceglecka-Tomaszewska K; Ziółkowski J
    Pneumonol Pol; 1982 Nov; 50(11):571-9. PubMed ID: 6985082
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospital-based ambulatory treatment of tuberculosis with capreomycin, ethambutol, and-or rifampicin.
    Riska N
    Scand J Respir Dis Suppl; 1969; 69():75-9. PubMed ID: 4906378
    [No Abstract]   [Full Text] [Related]  

  • 12. [New anti-tubercular agents--rifampicin and ethambutol].
    El'nik VI
    Klin Med (Mosk); 1971 May; 49(5):8-11. PubMed ID: 4946528
    [No Abstract]   [Full Text] [Related]  

  • 13. Methods of clinical evaluation of rifampicin-activity.
    Trendelenburg F
    Acta Tuberc Pneumol Belg; 1969; 60(3):432-6. PubMed ID: 4906099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sex-related differences in the level of rifampicin in humans and animals].
    Zwolska-Kwiek Z
    Pneumonol Pol; 1982 Nov; 50(11):563-9. PubMed ID: 7182813
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
    Schütz I
    Acta Tuberc Pneumol Belg; 1969; 60(3):437-41. PubMed ID: 4906990
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
    Grassi C
    Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.